Novavax’s COVID-19 vaccine won FDA approval in October 2023. It’s different from the mRNA vaccines developed by Pfizer Inc.

The Novavax shot is a more traditional protein vaccine combined ... But the store’s holiday display will look a bit different ...

While it is too early to know how this season’s flu will play out, we do know that COVID-19 is still with us.’ ...

Take a tour of a COVID-19 vaccine manufacturing facility in Montreal Francois-Philippe Champagne, federal minister of ...

Northeastern University professors of pharmacy say the updated COVID-19 vaccines available for fall and winter of 2024 are a ...

With flu season underway and new, developing COVID-19 strains, health professionals continue to stress the importance of receiving an updated vaccine. On Oct. 23, the Centers for Disease Control ...

An abundance of evidence indicates the mRNA COVID-19 vaccines are remarkably safe and work well to protect against severe ...

The CDC lowered the age for the pneumonia vaccination from 65 to 50 and recommended an extra COVID shot to some people.

But he noted that the circulating variants are not that different from the Novavax’s JN.1 target and that many of the antibodies people will make in response to the updated vaccines are aimed at ...

But he noted that the circulating variants are not that different from the Novavax’s JN.1 target and that many of the ...

Dr. Marty discusses why the FDA put a hold on the Novavax COVID-Flu vaccines and how their COVID vaccine is different from the others that are offered. She also explains the possible connections ...